Literature DB >> 12612611

Prion pathogenesis in the absence of Toll-like receptor signalling.

Marco Prinz1, Mathias Heikenwalder, Petra Schwarz, Kiyoshi Takeda, Shizuo Akira, Adriano Aguzzi.   

Abstract

To reach the brain from peripheral sites, prions must colonize various cell types within the lymphoreticular compartment. However, no prion entry receptors are yet known. Toll-like receptors (TLRs) are pattern-recognition receptors that bind a multitude of pathogens and are therefore candidates as effectors of prion entry. Moreover, injection of unmethylated CpG oligodinucleotides, which stimulate TLR9, has been reported to delay peripherally initiated scrapie. We therefore studied prion infection in MyD88(-/-) mice, which are defective in TLR signalling. Despite subtle defects in splenic microarchitecture, MyD88(-/-) mice challenged intraperitoneally or intracerebrally were fully susceptible to disease and died of scrapie after similar incubation times to those of wild-type mice. Splenic infectivity titres rose to similar levels with the same kinetics, and brains showed similar histopathological changes. TLR signalling therefore does not have any major role in prion pathogenesis, and the protective effect of TLR stimulation is unlikely to result from direct interactions with prions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612611      PMCID: PMC1315829          DOI: 10.1038/sj.embor.embor731

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  29 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity.

Authors:  Shneh Sethi; Grayson Lipford; Hermann Wagner; Hans Kretzschmar
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

3.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

4.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

5.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

7.  Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice.

Authors:  A E Williams; A M van Dam; W K Man-A-Hing; F Berkenbosch; P Eikelenboom; H Fraser
Journal:  Brain Res       Date:  1994-08-22       Impact factor: 3.252

8.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

Review 9.  Species-barrier-independent prion replication in apparently resistant species.

Authors:  Andrew F Hill; John Collinge
Journal:  APMIS       Date:  2002-01       Impact factor: 3.205

10.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  32 in total

Review 1.  The immunology of neurodegeneration.

Authors:  Eva Czirr; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

3.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease.

Authors:  Colm Cunningham; David C Wilcockson; Delphine Boche; V Hugh Perry
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Toll-like receptor 2 deficiency shifts PrP106-126-induced microglial activation from a neurotoxic to a neuroprotective phenotype.

Authors:  Jihong Wang; Deming Zhao; Bo Pan; Yongyao Fu; Fushan Shi; Mohammed Kouadir; Lifeng Yang; Xiaomin Yin; Xiangmei Zhou
Journal:  J Mol Neurosci       Date:  2014-10-21       Impact factor: 3.444

Review 6.  Protein aggregation diseases: pathogenicity and therapeutic perspectives.

Authors:  Adriano Aguzzi; Tracy O'Connor
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

7.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 8.  Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application.

Authors:  Dorit Trudler; Dorit Farfara; Dan Frenkel
Journal:  Mediators Inflamm       Date:  2010-07-25       Impact factor: 4.711

9.  NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.

Authors:  Iva Hafner-Bratkovič; Mojca Benčina; Katherine A Fitzgerald; Douglas Golenbock; Roman Jerala
Journal:  Cell Mol Life Sci       Date:  2012-08-29       Impact factor: 9.261

10.  Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice.

Authors:  Daryl S Spinner; In Soo Cho; Seung Yong Park; Jae Il Kim; Harry C Meeker; Xuemin Ye; Giuseppe Lafauci; Daniel J Kerr; Michael J Flory; Bo Sook Kim; Regina B Kascsak; Thomas Wisniewski; William R Levis; Georgia B Schuller-Levis; Richard I Carp; Eunkyue Park; Richard J Kascsak
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.